Wockhardt, Sinclair ink licensing pact

India's Wockhardt announced today that it has in-licensed dermatology and dental programs from he UK-based company Sinclair Pharma. Wockhardt will manufacture the drugs from bulk imported from Sinclair Pharma. The Indian company said it is also in talks with  Sinclair on contract manufacturing of the dermatology and dental products.

"As part of our India business strategy, in-licensing is seen as one of our key growth drivers. These in-licensing deals will fulfill our aim of getting niche global products for the benefit of our Indian patients," said Wockhardt Chairman Habil Khorakiwala. "We bring to India breakthrough products that have proved their effectiveness in Europe and USA and also strengthen our existing portfolios," he further added.

- here's the release from Wockhardt

Related Articles:
India eyes R&D opportunities
Wockhardt enters the US market with Zithromax